Market Data
Market Cap₹2,498.57 Cr.
52W High₹6,392
Current Price₹5,170
52W Low₹4,412.05
Down from 52W High19.1 %
Face Value₹10
Performance
ROCE16.64 %
ROE22.01 %
EPS (TTM)₹48.38
EPS Prev Qtr₹33.6
EPS Last Year₹41.04
EBITDA Qtr₹31.77 Cr.
Book Value₹716
Financial Health
Debt/Equity0.94
Debt/Profit4.28
Total Assets₹766.46 Cr.
Dividend Yield0.08 %
Promoter Holding72.67 %
Earning Power13.68 %
Valuation
Stock P/E32.56
Industry P/E40.59
Price to Book7.22
Price to Sales5.03
Graham Number₹1,599.43
Key Metrics
Dividend/Share
₹3
Face Value
₹10
About Dr Agarwals Eye Hospital Ltd
Healthcare · Healthcare
Dr Agarwals Eye Hospital Ltd is listed on NSE in the Healthcare / Healthcare sector. Face value ₹10. Market cap ₹2,498.57 Cr.
Price Chart
Strengths & Weaknesses
Strengths
- The company has a high ROCE of 36.56%, indicating efficient use of capital.
- ROE is strong at 36.36%, reflecting profitability relative to shareholder equity.
- The promoter holding is substantial at 72.67%, suggesting strong management control.
- The company maintains a conservative debt-to-equity ratio of 0.46, indicating lower financial risk.
Weaknesses
- The P/E ratio of 33.48 suggests the stock may be overvalued relative to earnings.
- The P/B ratio of 12.26 indicates the market values the company at a premium to its book value.
- The dividend yield is very low at 0.08%, which may not attract income-focused investors.
Peer Comparison
| Name | CMP | P/E | Market Cap | Div Yield | NP Qtr | Qtr Profit Var% | Sales Qtr | Qtr Sales Var% | ROCE% | Debt/Eq |
|---|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Ltd | - | 59.87 | ₹1,25,119.97 Cr | 0.23% | ₹2,172 Cr | - | ₹26,429.9 Cr | - | 22.05% | 0.6 |
| Manipal Health Enterprises Ltd | - | - | ₹98,508.6 Cr | - | - | - | - | - | - | 1.25 |
| Max Healthcare Institute Ltd | - | 65.64 | ₹95,762.32 Cr | 0.2% | ₹1,457.4 Cr | - | ₹8,712.05 Cr | - | 14.38% | 0.27 |
| Aster DM Quality Care Ltd | - | 118.98 | ₹64,094.07 Cr | 0.41% | ₹362.82 Cr | - | ₹4,876.03 Cr | - | 12.95% | 0.17 |
| Fortis Healthcare Ltd | - | 59.01 | ₹61,831.07 Cr | 0.12% | ₹1,070.21 Cr | - | ₹9,506.15 Cr | - | 13.34% | 0.29 |
| Global Health Ltd | - | 68.38 | ₹38,058.8 Cr | - | ₹552.33 Cr | - | ₹4,683.41 Cr | - | 21.87% | 0.1 |
| Narayana Hrudayalaya Ltd | - | 44.88 | ₹36,850.34 Cr | - | ₹816.55 Cr | - | ₹9,072.4 Cr | - | 13.65% | 1.07 |
| Dr Lal Pathlabs Ltd | - | 47.16 | ₹32,792.46 Cr | 1.25% | ₹546.3 Cr | - | ₹2,890.8 Cr | - | 29.55% | 0 |
| Krishna Institute of Medical Sciences Ltd | - | 151 | ₹32,344.7 Cr | - | ₹194.4 Cr | - | ₹4,212.5 Cr | - | 9.66% | 1.44 |
| Poly Medicure Ltd | - | 52.78 | ₹16,633.09 Cr | 0.21% | ₹312.92 Cr | - | ₹1,997.43 Cr | - | 15.07% | 0.06 |
| Dr Agarwals Health Care Ltd | - | 105.51 | ₹15,685.91 Cr | - | ₹185.1 Cr | - | ₹2,206.68 Cr | - | 16.46% | 0.08 |
| Vijaya Diagnostic Centre Ltd | - | 81.03 | ₹15,200.42 Cr | 0.14% | ₹187.49 Cr | - | ₹857.13 Cr | - | 36.21% | 0 |
| Syngene International Ltd | - | 66.95 | ₹14,863.1 Cr | 0.34% | ₹221 Cr | - | ₹3,600.2 Cr | - | 6.95% | 0 |
| Indegene Ltd | - | 36.18 | ₹14,568.1 Cr | 0.37% | ₹400.9 Cr | - | ₹3,812.8 Cr | - | 17.45% | 0 |
| Molbio Diagnostics Ltd | - | - | ₹14,188.59 Cr | - | - | - | - | - | - | 0.35 |
| Rainbow Childrens Medicare Ltd | - | 48.68 | ₹13,896.34 Cr | 0.26% | ₹290.28 Cr | - | ₹1,820.14 Cr | - | 27.05% | 0 |
| Park Medi World Ltd | - | 38.3 | ₹11,942.89 Cr | - | ₹296.75 Cr | - | ₹1,756.29 Cr | - | 19.17% | 0.11 |
| Metropolis Healthcare Ltd | - | 24.09 | ₹11,664.5 Cr | 0.89% | ₹202.82 Cr | - | ₹1,710 Cr | - | 19.8% | 0.01 |
| Yatharth Hospital & Trauma Care Services Ltd | - | 58.81 | ₹10,653.42 Cr | - | ₹174.45 Cr | - | ₹1,334.1 Cr | - | 11.7% | 0.14 |
| Healthcare Global Enterprises Ltd | - | 452.55 | ₹10,472.8 Cr | - | ₹33.26 Cr | - | ₹2,627.35 Cr | - | 9.41% | 0.68 |
Quarterly Results
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Sales | 117.72 | 116.22 | 120.01 | 142.97 |
| ↳ QoQ Growth | - | -1.3% | +3.3% | +19.1% |
| Expenses | 88.95 | 93.51 | 98.37 | 111.2 |
| Operating Profit | 28.77 | 22.71 | 21.64 | 31.77 |
| OPM % | 24.44% | 19.54% | 18.03% | 22.22% |
| Other Income | 0.68 | 2.77 | 1.57 | 1.96 |
| Interest | 3.73 | 2.03 | 1.96 | 2.77 |
| Depreciation | 11.31 | 11.66 | 12.09 | 11.49 |
| EBITDA | 40.08 | 34.37 | 33.73 | 43.26 |
| EBITDA Margin % | 34.05% | 29.57% | 28.11% | 30.26% |
| Profit Before Tax | 25.72 | 23.45 | 21.25 | 30.96 |
| Tax % | 24.88% | 26.31% | 23.58% | 24.48% |
| Net Profit | 19.32 | 17.28 | 16.24 | 23.38 |
| ↳ QoQ Growth | - | -10.6% | -6.0% | +44.0% |
| EPS | 41.04 | 35.76 | 33.6 | 48.38 |
Balance Sheet
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Equity Capital | 4.7 | 4.83 |
| Reserves | 204.91 | 341.47 |
| Borrowings | 96.36 | 326.13 |
| Other Liabilities | 307.35 | 94.03 |
| Total Liabilities | 613.32 | 766.46 |
| Fixed Assets | 393.19 | 374.82 |
| CWIP | 127.98 | 197.32 |
| Investments | 12.63 | 89.06 |
| Other Assets | 79.52 | 105.26 |
| Total Assets | 613.32 | 766.46 |
Cash Flows
| Mar 2025 | |
|---|---|
| Cash from Operating Activity | 94.48 |
| Cash from Investing Activity | -132.78 |
| Cash from Financing Activity | 16.58 |
| Net Cash Flow | -21.72 |
Shareholding Pattern
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Promoters % | 72.67% | 72.67% | 72.67% | 72.67% |
| FIIs % | 1.74% | 1.82% | 2.2% | 2.24% |
| DIIs % | 2.36% | 2.36% | 2.12% | 2.05% |
| Public % | 18.17% | 17.96% | 17.93% | 18.01% |
| No. of Shareholders | 30,528 | 25,449 | 24,036 | 22,954 |
Major Shareholders (>1%)
- Dr. Agarwal's Health Care LimitedPromoter and Promoter Group72.67%
- Malabar India Fund LimitedPublic Shareholding2.16%
- Varun Ashok HiremathPublic Shareholding2.11%
- Malabar Midcap FundPublic Shareholding1.66%
As of 2026-06-30View all shareholders →